PL1773829T3 - Pochodne aminotropanu, ich wytwarzanie oraz ich zastosowania terapeutyczne - Google Patents

Pochodne aminotropanu, ich wytwarzanie oraz ich zastosowania terapeutyczne

Info

Publication number: PL1773829T3
Authority: PL; Poland
Prior art keywords: amino; preparation; therapeutic use; tropane derivatives; tropane
Prior art date: 2004-07-29

Application number

PL05790816T

Other languages

English (en)

Inventor

Alain Braun

Bruno Cornet

Gilles Courtemanche

Olivier Crespin

Cécile Pascal

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-29

Filing date

2005-07-20

Publication date

2009-06-30

2005-07-20 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2009-06-30 Publication of PL1773829T3 publication Critical patent/PL1773829T3/pl

Links

FHPZUVVXVRYZAS-SFYZADRCSA-N (1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-5-amine Chemical class C1CC[C@@]2(N)CC[C@]1([H])N2C FHPZUVVXVRYZAS-SFYZADRCSA-N 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Addiction (AREA)
Emergency Medicine (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Child & Adolescent Psychology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL05790816T 2004-07-29 2005-07-20 Pochodne aminotropanu, ich wytwarzanie oraz ich zastosowania terapeutyczne PL1773829T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0408372A FR2873693B1 (fr)	2004-07-29	2004-07-29	Derives d'amino-tropane, leur preparation et leur application en therapeutique
EP05790816A EP1773829B1 (fr)	2004-07-29	2005-07-20	Derives d'amino-tropane, leur preparation et leurs applications en therapeutique
PCT/FR2005/001856 WO2006021657A1 (fr)	2004-07-29	2005-07-20	Derives d'amino-tropane, leur preparation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
PL1773829T3 true PL1773829T3 (pl)	2009-06-30

Family

ID=34947491

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05790816T PL1773829T3 (pl)	2004-07-29	2005-07-20	Pochodne aminotropanu, ich wytwarzanie oraz ich zastosowania terapeutyczne

Country Status (26)

Country	Link
US (1)	US7569582B2 (pl)
EP (1)	EP1773829B1 (pl)
JP (1)	JP2008508242A (pl)
KR (1)	KR20070047803A (pl)
CN (1)	CN101010320B (pl)
AR (1)	AR050019A1 (pl)
AT (1)	ATE417846T1 (pl)
AU (1)	AU2005276355B2 (pl)
BR (1)	BRPI0513923A (pl)
CA (1)	CA2574517A1 (pl)
CY (1)	CY1108878T1 (pl)
DE (1)	DE602005011818D1 (pl)
DK (1)	DK1773829T3 (pl)
ES (1)	ES2319918T3 (pl)
FR (1)	FR2873693B1 (pl)
HR (1)	HRP20090160T1 (pl)
IL (1)	IL180797A (pl)
MX (1)	MX2007001023A (pl)
PE (1)	PE20060575A1 (pl)
PL (1)	PL1773829T3 (pl)
PT (1)	PT1773829E (pl)
RU (1)	RU2389727C2 (pl)
SI (1)	SI1773829T1 (pl)
TW (1)	TW200617005A (pl)
UY (1)	UY29040A1 (pl)
WO (1)	WO2006021657A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2873690B1 (fr) *	2004-07-29	2006-10-13	Sanofi Synthelabo	Derives d'oxopiperidine, leur preparation et leur application en therapeutique
FR2873691B1 (fr) *	2004-07-29	2006-10-06	Sanofi Synthelabo	Derives d'amino-piperidine, leur preparation et leur application en therapeutique
WO2007028770A1 (en) *	2005-09-05	2007-03-15	Neurosearch A/S	Monoamine neurotransmitter re-uptake inhibitors for neuroprotection in patients suffering from an advanced stage of a mental disease
PL2305263T3 (pl) *	2007-06-07	2012-12-31	Novartis Ag	Stabilizowane amorficzne formy mesylanu imatinibu
EP2025674A1 (de)	2007-08-15	2009-02-18	sanofi-aventis	Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
SG2012079653A (en) *	2007-10-25	2014-05-29	Exelixis Inc	Tropane compounds
US8153653B2 (en) *	2010-06-22	2012-04-10	Hoffmann-La Roche Inc.	Amido-tropane derivatives
WO2012120058A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8895547B2 (en)	2011-03-08	2014-11-25	Sanofi	Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2012120051A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2269128C (en) *	1996-10-30	2005-01-11	Schering Corporation	Piperazino derivatives as neurokinin antagonists
US5968929A (en) *	1996-10-30	1999-10-19	Schering Corporation	Piperazino derivatives as neurokinin antagonists
FR2762316B1 (fr) *	1997-04-18	1999-12-17	Sanofi Synthelabo	Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
CA2432988A1 (en) *	2001-01-23	2002-08-01	Cristina Garcia-Paredes	Melanocortin receptor agonists
US7115628B2 (en) *	2001-07-18	2006-10-03	Merck & Co., Inc.	Bridged piperidine derivatives as melanocortin receptor agonists
WO2003061660A1 (en) *	2002-01-23	2003-07-31	Eli Lilly And Company	Melanocortin receptor agonists

2004
- 2004-07-29 FR FR0408372A patent/FR2873693B1/fr not_active Expired - Fee Related
2005
- 2005-07-20 SI SI200530620T patent/SI1773829T1/sl unknown
- 2005-07-20 PT PT05790816T patent/PT1773829E/pt unknown
- 2005-07-20 DK DK05790816T patent/DK1773829T3/da active
- 2005-07-20 CN CN2005800292441A patent/CN101010320B/zh not_active Expired - Fee Related
- 2005-07-20 EP EP05790816A patent/EP1773829B1/fr not_active Expired - Lifetime
- 2005-07-20 HR HR20090160T patent/HRP20090160T1/xx unknown
- 2005-07-20 AU AU2005276355A patent/AU2005276355B2/en not_active Ceased
- 2005-07-20 RU RU2007107372/04A patent/RU2389727C2/ru not_active IP Right Cessation
- 2005-07-20 AT AT05790816T patent/ATE417846T1/de active
- 2005-07-20 WO PCT/FR2005/001856 patent/WO2006021657A1/fr not_active Ceased
- 2005-07-20 BR BRPI0513923-6A patent/BRPI0513923A/pt not_active IP Right Cessation
- 2005-07-20 MX MX2007001023A patent/MX2007001023A/es active IP Right Grant
- 2005-07-20 DE DE602005011818T patent/DE602005011818D1/de not_active Expired - Lifetime
- 2005-07-20 CA CA002574517A patent/CA2574517A1/fr not_active Abandoned
- 2005-07-20 ES ES05790816T patent/ES2319918T3/es not_active Expired - Lifetime
- 2005-07-20 JP JP2007523110A patent/JP2008508242A/ja active Pending
- 2005-07-20 KR KR1020077004658A patent/KR20070047803A/ko not_active Ceased
- 2005-07-20 PL PL05790816T patent/PL1773829T3/pl unknown
- 2005-07-27 AR ARP050103112A patent/AR050019A1/es not_active Application Discontinuation
- 2005-07-28 UY UY29040A patent/UY29040A1/es not_active Application Discontinuation
- 2005-07-28 TW TW094125585A patent/TW200617005A/zh unknown
- 2005-08-01 PE PE2005000887A patent/PE20060575A1/es not_active Application Discontinuation
2007
- 2007-01-18 IL IL180797A patent/IL180797A/en not_active IP Right Cessation
- 2007-01-25 US US11/626,973 patent/US7569582B2/en not_active Expired - Fee Related
2009
- 2009-03-17 CY CY20091100292T patent/CY1108878T1/el unknown

Also Published As

Publication number	Publication date
AU2005276355B2 (en)	2011-08-25
PT1773829E (pt)	2009-03-26
JP2008508242A (ja)	2008-03-21
RU2389727C2 (ru)	2010-05-20
BRPI0513923A (pt)	2008-05-20
UY29040A1 (es)	2006-02-24
MX2007001023A (es)	2007-04-16
RU2007107372A (ru)	2008-09-10
WO2006021657A1 (fr)	2006-03-02
EP1773829B1 (fr)	2008-12-17
CN101010320B (zh)	2011-11-16
SI1773829T1 (sl)	2009-06-30
US20070191361A1 (en)	2007-08-16
TW200617005A (en)	2006-06-01
PE20060575A1 (es)	2006-08-02
FR2873693A1 (fr)	2006-02-03
FR2873693B1 (fr)	2006-09-15
ATE417846T1 (de)	2009-01-15
ES2319918T3 (es)	2009-05-14
US7569582B2 (en)	2009-08-04
CA2574517A1 (fr)	2006-03-02
AR050019A1 (es)	2006-09-20
HRP20090160T1 (en)	2009-05-31
DK1773829T3 (da)	2009-04-20
KR20070047803A (ko)	2007-05-07
IL180797A (en)	2011-02-28
IL180797A0 (en)	2007-06-03
EP1773829A1 (fr)	2007-04-18
CN101010320A (zh)	2007-08-01
DE602005011818D1 (de)	2009-01-29
AU2005276355A1 (en)	2006-03-02
CY1108878T1 (el)	2014-07-02

Publication	Publication Date	Title
IL180284A0 (en)	2007-07-04	2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL180770A0 (en)	2007-06-03	Oxopiperidine derivatives, preparation and therapeutic use thereof
IL180682A0 (en)	2007-06-03	N-hydroxamide derivatives, their preparation and use
IL178402A0 (en)	2007-02-11	1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
IL181069A0 (en)	2007-07-04	Sulphonamide derivatives , their preparation and their therapeutic application
IL182624A0 (en)	2007-07-24	2-amido-4 phenylthiazole derivatives, the preparation and the therapeutic use thereof
SI2069342T1 (sl)	2010-09-30	Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
TWI350286B (en)	2011-10-11	Alkylpiperazine- and alkylhomopiperazine-carboxylate derivatives, their preparation and their application in therapy
IL180797A0 (en)	2007-06-03	Amino-tropane derivatives, preparation thereof and therapeutic use thereof
HRP20041157B1 (en)	2012-11-30	Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
IL184008A0 (en)	2007-10-31	4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
IL177047A0 (en)	2006-12-10	Oxazole derivatives, preparation and therapeutic use thereof
PT1525193E (pt)	2008-02-25	Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide
IL190519A0 (en)	2008-11-03	6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
TWI350287B (en)	2011-10-11	Acylaminothiazole derivatives, their preparation and their therapeutic application
IL180867A0 (en)	2007-07-04	Pyrrole derivatives, their preparation and their therapeutic use
IL182385A0 (en)	2007-07-24	Pyridine derivatives and the preparation and the therapeutic use thereof
PT1776340E (pt)	2009-02-20	Derivados de n-(1h-indolil)-1h-indole-2-carboxamidas, sua preparação e sua aplicação em terapêutica
ZA200800439B (en)	2009-04-29	N-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives, preparation and therapeutic use thereof
PL375309A1 (pl)	2005-11-28	Pochodne acyloksypirolidyny, ich wytwarzanie i ich zastosowanie lecznicze
IL191892A0 (en)	2008-12-29	2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
TWI340642B (en)	2011-04-21	Acylaminothiazole derivatives, preparation and therapeutic application thereof
ZA200700603B (en)	2008-10-29	4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
ZA200704806B (en)	2008-09-25	Novel betulin derivatives, preparation thereof and use thereof
IL177632A0 (en)	2006-12-31	2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof